The World Bank pioneered global HIV/AIDS financing early in the emergency and remains 100 percent committed to halting and reversing the spread of the pandemic. The Bank assists countries by providing resources, generating and sharing knowledge, technical assistance and capacity building, and forging partnerships in the public and private sectors. Since 1989, Bank financing for HIV/AIDS has totaled nearly $4.6 billion.
The Bank has helped 77 countries finance national responses and thousands of community-driven projects, and has funded hundreds of analytical studies to better understand the epidemiology and social drivers of the disease as well as cost-effective ways for countries to finance, design, and deliver prevention, treatment and care.
A founding partner and one of the ten co-sponsors of the UNAIDS Program, the Bank is a major player in the global response to HIV/AIDS. Among its UNAIDS partners , the Bank plays a global leadership role in three key areas, consistent with its regional priorities for HIV:
i) Strategic Intelligence and Operational Planning —to strengthen evidence for strategic, prioritized, costed national AIDS plans.
ii) Prevention of Sexual Transmission of HIV—to reduce sexual transmission of HIV by supporting countries to analyze their HIV epidemics and design HIV prevention strategies appropriate to epidemic contexts; collect better evidence of what works in HIV prevention; and implement more robust HIV prevention programs.
iii) Social Protection for People Affected by HIV/AIDS — to mainstream HIV-sensitive policies into social protection systems and enhance social protection for people affected by HIV.
In setting HIV/AIDS strategy, Bank experts, member governments, and international partners ask: Are resources for global health, including HIV, being allocated efficiently? Are action plans well-developed and evidence-based? Do programs designed to help communities prevent and cope with AIDS have the desired impact? How can developing countries sustain their national responses to HIV/AIDS?
To help answer these questions, the Bank leverages its roles in financing, implementation support, analytical work, and knowledge generation to help countries improve their responses to HIV/AIDS through four service lines:
- Allocative efficiency to ensure that scarce resources flow to the programs that are most likely to produce the best results.
- Program efficiency and sustainability to ensure that a given HIV program achieves its intended goals in the most efficient way.
- Prevention response evaluations to invest in prevention measures that really work to reduce the spread of HIV.
- Results to ensure programs are cost-effective and provide the intended return on investment.
Allocative Efficiency: The Bank assists countries to allocate their scarce AIDS resources more effectively, to ensure resources target those at highest risk of transmitting HIV and geographic areas of high transmission, with proven, cost-effective interventions aligned to epidemic context. The Bank supports countries in implementing epidemic, policy and response synthesis and expenditure tracking surveys and analyses. These syntheses help countries to better characterize their HIV epidemic and improve HIV prevention programming. Bank experts also assist countries to conduct bio-behavioral surveys and epidemiological syntheses to inform the design and targeting of AIDS projects. Bank-supported, population-based bio-behavioral surveys help to expose misalignment of AIDS resources. The Bank responds by helping countries to focus resources and interventions on epidemic priorities.
HIV program efficiency and sustainability: The Bank supports countries to understand and improve their HIV service delivery efficiency, institutional efficiency, transactional and administrative efficiency, and information efficiency, as well as HIV funding sustainability.
HIV prevention response evaluations: How can a country identify and invest in prevention measures that really work to reduce the spread of HIV? The Bank helps countries to understand the efficacy and effectiveness of HIV prevention responses through evaluations and to estimate population level effectiveness.
Results: How do you determine that an HIV program is cost-effective and will provide the intended return on investment? The Bank helps countries develop tools to conduct HIV cost effectiveness analyses of HIV responses, develop appropriate models for intervention support, and undertake return on investment studies to make economic arguments for investing in HIV responses.